[1]
Ostrowska, M. et al. 2022. Review of commercially available biomarkers in the diagnosis of prostate cancer. Journal of Education, Health and Sport. 12, 11 (Nov. 2022), 192–197. DOI:https://doi.org/10.12775/JEHS.2022.12.11.025.